Oxford University

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Scripta Therapeutics raises £9m seed led by Oxford Science Enterprises and Apollo Health Ventures to upend conventional drug discovery

14 Nov 2025

Scripta Therapeutics raises £9m seed led by Oxford Science Enterprises and Apollo Health Ventures to upend conventional drug discovery

Scripta Therapeutics applies AI and experimental biology to map disease-driving transcription networks, aiming to identify new drug targets for neurodegenerative and complex conditions.

Wild Bio

16 Oct 2025

Wild Bio secures £45m Series A led by the Ellison Institute of Technology to boost crop resilience by learning from wild species

Wild Bio applies AI and precision breeding to crop genetics, using insights from wild plant species to develop climate-resilient, higher-yield crop varieties for commercial agriculture.

Ultromics

31 Jul 2025

Ultromics raises £40m Series C led by L&G, Allegis Capital and Lightrock to expand AI heart failure diagnostics in the US

Ultromics develops AI software that analyses echocardiograms to help clinicians detect hard-to-diagnose heart failure conditions earlier, without requiring new hardware or changes to existing clinical workflows.

Oxford University